- Home
- CDIO vs SBFM Comparison
CDIO vs SBFM Comparison
Compare CDIO & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- SBFM
- Stock Information
- Founded
- CDIO 2017
- SBFM 2006
- Country
- CDIO United States
- SBFM United States
- Employees
- CDIO N/A
- SBFM N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- CDIO Health Care
- SBFM Health Care
- Exchange
- CDIO Nasdaq
- SBFM Nasdaq
- Market Cap
- CDIO 6.4M
- SBFM 6.5M
- IPO Year
- CDIO N/A
- SBFM N/A
- Fundamental
- Price
- CDIO $3.63
- SBFM $1.49
- Analyst Decision
- CDIO Buy
- SBFM Strong Buy
- Analyst Count
- CDIO 1
- SBFM 1
- Target Price
- CDIO $60.00
- SBFM $15.00
- AVG Volume (30 Days)
- CDIO 41.9K
- SBFM 54.6K
- Earning Date
- CDIO 08-14-2025
- SBFM 08-12-2025
- Dividend Yield
- CDIO N/A
- SBFM N/A
- EPS Growth
- CDIO N/A
- SBFM N/A
- EPS
- CDIO N/A
- SBFM N/A
- Revenue
- CDIO $19,507.00
- SBFM $36,341,741.00
- Revenue This Year
- CDIO $1,434.82
- SBFM $32.20
- Revenue Next Year
- CDIO $4,661.91
- SBFM $32.74
- P/E Ratio
- CDIO N/A
- SBFM N/A
- Revenue Growth
- CDIO N/A
- SBFM 19.22
- 52 Week Low
- CDIO $3.22
- SBFM $1.17
- 52 Week High
- CDIO $53.10
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- CDIO 41.96
- SBFM 51.16
- Support Level
- CDIO $3.58
- SBFM $1.35
- Resistance Level
- CDIO $4.05
- SBFM $1.52
- Average True Range (ATR)
- CDIO 0.33
- SBFM 0.08
- MACD
- CDIO -0.01
- SBFM 0.01
- Stochastic Oscillator
- CDIO 24.74
- SBFM 66.30
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.